Regulation of p27Kip1 by mitogen-induced tyrosine phosphorylation
暂无分享,去创建一个
[1] Jung Weon Lee,et al. JNK signaling activity regulates cell-cell adhesions via TM4SF5-mediated p27(Kip1) phosphorylation. , 2012, Cancer letters.
[2] L. Hengst,et al. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control , 2011, Oncogene.
[3] D. Bowtell,et al. Siah1/SIP regulates p27kip1 stability and cell migration under metabolic stress , 2011, Cell cycle.
[4] Zhenlin Ju,et al. Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo , 2011, Breast Cancer Research and Treatment.
[5] D. Bashford,et al. Incomplete Folding upon Binding Mediates Cdk4/Cyclin D Complex Activation by Tyrosine Phosphorylation of Inhibitor p27 Protein* , 2011, The Journal of Biological Chemistry.
[6] Karl A. Merrick,et al. Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation. , 2011, Molecular cell.
[7] R. Kriwacki,et al. The role of the LH subdomain in the function of the Cip/Kip cyclin-dependent kinase regulators. , 2011, Biophysical journal.
[8] A. Deblasio,et al. JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. , 2011, Cancer cell.
[9] K. Fukunaga,et al. CaMKII phosphorylates serine 10 of p27 and confers apoptosis resistance to HeLa cells. , 2010, Biochemical and biophysical research communications.
[10] Andrew J. Bannister,et al. LIF independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease , 2010, Nature Cell Biology.
[11] P. Boya,et al. Tumor suppressor p27Kip1 undergoes endolysosomal degradation through its interaction with sorting nexin 6 , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] T. Hunter,et al. Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors , 2010, Cell cycle.
[13] N. Nozaki,et al. Interaction of human MCM2-7 proteins with TIM, TIPIN and Rb. , 2010, Journal of biochemistry.
[14] K. Coulonval,et al. Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase , 2010, Cell cycle.
[15] Riaan Conradie,et al. Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex , 2010, The FEBS journal.
[16] J. Slingerland,et al. p27 as Jekyll and Hyde: Regulation of cell cycle and cell motility , 2009, Cell cycle.
[17] Andrew J. Bannister,et al. JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin , 2009, Nature.
[18] T. Naoe,et al. p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation. , 2009, Biochemical and biophysical research communications.
[19] D. Helfman,et al. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility , 2009, Proceedings of the National Academy of Sciences.
[20] S. Paternot,et al. Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation , 2009, Molecular and Cellular Biology.
[21] M. Barbacid,et al. Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.
[22] W. J. Pledger,et al. Inhibition of p27Kip1 gene transcription by mitogens , 2009, Cell cycle.
[23] R. P. Fisher,et al. p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes , 2008, Molecular and Cellular Biology.
[24] R. Assoian,et al. Transcriptional regulation of the cyclin D1 gene at a glance , 2008, Journal of Cell Science.
[25] W. Vainchenker,et al. Miscreant myeloproliferative disorder stem cells , 2008, Leukemia.
[26] Shunichi Takeda,et al. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? , 2008, Nature Reviews Molecular Cell Biology.
[27] K. Nakayama,et al. Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease. , 2008, Blood.
[28] J. Slingerland,et al. Phosphorylation of p27Kip1 Regulates Assembly and Activation of Cyclin D1-Cdk4 , 2008, Molecular and Cellular Biology.
[29] T. Tsuruo,et al. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. , 2008, Cancer research.
[30] M. Pagano,et al. Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer , 2008, Nature Reviews Cancer.
[31] M. Tomasson,et al. The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes. , 2008, Blood.
[32] Ludger Hengst,et al. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy , 2008, Nature Reviews Cancer.
[33] S. Blain. Switching cyclin D-Cdk4 kinase activity on and off , 2008, Cell cycle.
[34] James M. Roberts,et al. CDK inhibitors: cell cycle regulators and beyond. , 2008, Developmental cell.
[35] S. Rane,et al. Hematopoietic cytokine receptor signaling , 2007, Oncogene.
[36] S. Blain,et al. Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity , 2007, Molecular and Cellular Biology.
[37] D. Gary Gilliland,et al. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders , 2007, Nature Reviews Cancer.
[38] James M. Roberts,et al. A Skp2 autoinduction loop and restriction point control , 2007, The Journal of cell biology.
[39] Gordon B. Mills,et al. The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis , 2007, Nature Cell Biology.
[40] L. Hengst,et al. p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 , 2007, Cell.
[41] Richard W. Kriwacki,et al. Cdk-Inhibitory Activity and Stability of p27 Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases , 2007, Cell.
[42] M. Manns,et al. C‐terminal phosphorylation controls the stability and function of p27kip1 , 2006, The EMBO journal.
[43] Yang Guo,et al. p27Kip1 and Cyclin Dependent Kinase 2 Regulate Passage Through the Restriction Point , 2006, Cell cycle.
[44] G. Bjursell,et al. Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells , 2006, Molecular and Cellular Biology.
[45] L. Hengst,et al. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression. , 2006, Cancer research.
[46] K. Welte,et al. Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4. , 2006, Blood.
[47] E. Musgrove. Cyclins: Roles in mitogenic signaling and oncogenic transformation , 2006, Growth factors.
[48] H. Lodish,et al. Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] E. Nabel,et al. The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication , 2005, FEBS letters.
[50] J. Diehl,et al. Location, location, location: The role of cyclin D1 nuclear localization in cancer , 2005, Journal of cellular biochemistry.
[51] G. Viglietto,et al. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. , 2005, Carcinogenesis.
[52] Mario Cazzola,et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.
[53] Stefan N. Constantinescu,et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.
[54] Sandra A. Moore,et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.
[55] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.
[56] Xin Lu,et al. Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo. , 2005, Blood.
[57] Y. Kotake,et al. Role of Serine 10 Phosphorylation in p27 Stabilization Revealed by Analysis of p27 Knock-in Mice Harboring a Serine 10 Mutation* , 2005, Journal of Biological Chemistry.
[58] P. Heinrich,et al. Janus Kinase (Jak) Subcellular Localization Revisited , 2004, Journal of Biological Chemistry.
[59] L. Hengst,et al. p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding , 2004, Nature Structural &Molecular Biology.
[60] E. Friedman,et al. The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase* , 2004, Journal of Biological Chemistry.
[61] J. Dumont,et al. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. , 2003, Experimental cell research.
[62] K. Nakayama,et al. Estrogens Down-regulate p27Kip1 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway* , 2003, Journal of Biological Chemistry.
[63] M. Pagano,et al. Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions , 2003, Molecular and Cellular Biology.
[64] Takashi Tsuruo,et al. Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization* , 2002, The Journal of Biological Chemistry.
[65] F. McCormick,et al. The RB and p53 pathways in cancer. , 2002, Cancer cell.
[66] E. Nabel,et al. A growth factor‐dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression , 2002, The EMBO journal.
[67] J. Slingerland,et al. Altered p27Kip1 Phosphorylation, Localization, and Function in Human Epithelial Cells Resistant to Transforming Growth Factor β-Mediated G1 Arrest , 2002, Molecular and Cellular Biology.
[68] Mikhail V. Blagosklonny,et al. The Restriction Point of the Cell Cycle , 2002, Cell cycle.
[69] L. Di Marcotullio,et al. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis , 2001, The EMBO journal.
[70] M. Kitagawa,et al. Phosphorylation at Serine 10, a Major Phosphorylation Site of p27 Kip1 , Increases Its Protein Stability* , 2000, The Journal of Biological Chemistry.
[71] H. Baumann,et al. Oncostatin M and Interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells , 2000, Oncogene.
[72] K. Hirano,et al. Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor. , 2000, Biochemical and biophysical research communications.
[73] J. Harbour,et al. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.
[74] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[75] N. Pavletich. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. , 1999, Journal of molecular biology.
[76] B. Schulman,et al. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[77] J. Marine,et al. Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.
[78] D. Waxman,et al. Interaction of Growth Hormone-activated STATs with SH2-containing Phosphotyrosine Phosphatase SHP-1 and Nuclear JAK2 Tyrosine Kinase* , 1997, The Journal of Biological Chemistry.
[79] J. Massagué,et al. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.
[80] O. Silvennoinen,et al. Constitutive nuclear localization of Janus kinases 1 and 2. , 1996, Endocrinology.
[81] Philip D. Jeffrey,et al. Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.
[82] L. Hengst,et al. Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.
[83] R. Sorenson,et al. Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. , 1995, Endocrinology.
[84] P. Beer-Romero,et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.
[85] James M. Roberts,et al. Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.
[86] C. Sherr,et al. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase , 1994, Molecular and cellular biology.
[87] A. Pardee,et al. A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[88] E. P. Kay,et al. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells. , 2008, Investigative ophthalmology & visual science.
[89] James M. Roberts,et al. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. , 2006, Genes & development.
[90] M. Hoshino,et al. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration , 2006, Nature Cell Biology.
[91] L. Hengst,et al. CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. , 2003, Molecular biology of the cell.
[92] J. Slingerland,et al. Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. , 2002, Molecular and cellular biology.
[93] Heinz Höfler,et al. Open Access Research Characterization of a Naturally-occurring P27 Mutation Predisposing to Multiple Endocrine Tumors , 2022 .